U.S. Personal Products Stock News

Wondering if Inspire Medical Systems at around US$56.69 is a bargain or a value trap? This article focuses on what the current price really implies about the stock. The share price has seen mixed recent moves, with a 3.1% gain over the last 7 days, a 4.6% decline over 30 days, and year to date and 1 year returns of 38.6% and 60.8% declines respectively. Recent coverage has focused on how the share price performance over multiple time frames compares to broader market and industry moves,...

Why Scotts Miracle-Gro is drawing fresh attention Scotts Miracle-Gro (SMG) is back on investors’ radar after recent share price swings and updated performance metrics. This is prompting a closer look at how its lawn and garden business aligns with current portfolio goals. See our latest analysis for Scotts Miracle-Gro. Recent trading has been choppy, with a 1-day share price return of a 2.01% decline and a 7-day share price return of a 2.10% decline. However, the 1-year total shareholder...

Q4 results and Exzeo IPO shift focus to HCI Group HCI Group (HCI) is back on investors’ radar after Q4 revenue grew 52.1% year on year, earnings reached record levels for 2025, and the company completed the IPO of its technology platform, Exzeo. See our latest analysis for HCI Group. Despite the strong Q4 update and the Exzeo IPO, momentum in HCI Group’s share price has cooled. The 30 day share price return shows a decline of 4.21%, and the year to date share price return shows a decline of...

Context for CME Group after recent share performance CME Group (CME) shares have eased in the month and past week, with returns of about a 2% decline over 30 days and a 1% decline over 7 days, while the past 3 months show a roughly 14% gain. See our latest analysis for CME Group. The recent 1 day and 30 day share price declines sit against a stronger backdrop, with the 90 day share price return of 13.9% and 1 year total shareholder return of 20.1% pointing to momentum that has built over a...

Leadership move in aerospace and defense investment banking Oppenheimer Holdings (OPY) shares are in focus after subsidiary Oppenheimer & Co. appointed Bill Farmer as Managing Director and Head of Aerospace & Defense Technology Investment Banking, a role centered on mergers, acquisitions and capital markets execution. See our latest analysis for Oppenheimer Holdings. The leadership change comes as Oppenheimer Holdings’ share price has moved sharply higher in recent months, with a 30 day share...

If you are trying to figure out whether Fair Isaac at around US$1,072 per share is priced attractively or not, the starting point is understanding how its current market value lines up against different valuation checks. The stock has had a mixed run, with a 1.6% decline over the last week, a 16.6% decline over the last month, a 34.7% decline year to date, and a 42.0% decline over the last year, while still showing a 53.5% return over three years and 102.0% over five years. This kind of...

Wondering whether KKR at around US$92.83 is offering value or asking you to pay up? This breakdown will help you stress test what that price really means. The stock has seen mixed returns, with gains of 1.8% over the past week and 3.2% over the past month, set against a year to date return of a 28.0% decline and a 1 year return of an 8.3% decline, while the 3 year and 5 year returns sit at 82.5% and 83.1% respectively. Recent headlines around KKR have focused on its role as a large...

Fortinet recently held its APAC Demo Day – SASE Edition, while analysts continue to highlight an upcoming May 6, 2026 earnings report with expectations of EPS growth and higher revenue compared with last year. With analysts pointing to Fortinet’s consistent record of outperforming earnings forecasts and maintaining a Zacks Rank of #3 (Hold), the company’s ability to potentially exceed expectations again is drawing attention to its evolving mix of security and networking solutions. Next,...

Context for Cohen & Steers (CNS) after recent performance Cohen & Steers (CNS) has drawn fresh attention after a mixed stretch of returns, with modest gains over the past month contrasting with a negative move in the past 3 months and over the past year. See our latest analysis for Cohen & Steers. At a share price of US$64.04, Cohen & Steers has seen short-term share price momentum soften. This follows a 1-month gain of 1.28%, a 90-day share price return decline of 5.88%, and a 1-year total...

Wondering whether TransDigm Group at around US$1,225 per share is still priced for opportunity or already reflecting its strengths? This article walks you through what the current valuation actually says. The stock has returned 5.0% over the last 7 days, while the 30 day and year to date returns of 3.4% decline and 9.8% decline sit against a 0.9% return over the last year and 90.2% and 136.4% returns over 3 and 5 years. Recent coverage has focused on TransDigm Group's position in aerospace...

National Fuel Gas (NFG) has updated its financing toolkit by entering an Amended and Restated Credit Agreement that provides a US$1.3 billion unsecured revolving credit facility, extending liquidity coverage for routine needs and potential acquisitions. See our latest analysis for National Fuel Gas. That expanded credit facility arrives at a time when momentum in National Fuel Gas’s shares has been firm, with a 90-day share price return of 21.26% and a 1-year total shareholder return of...

NRG Energy recently expanded its contracted data center power capacity to about 445 megawatts and closed the LS Power portfolio acquisition, roughly doubling its generation fleet to around 25 gigawatts while updating its 2026 financial guidance. These moves deepen NRG’s role in supplying power to AI and data center customers, while adding a commercial virtual power plant platform that could reshape how it monetizes flexible generation and grid services. We’ll now examine how the LS Power...

Wondering if Oncolytics Biotech at US$1.04 is priced for its potential or already running ahead of itself? This article walks through what the numbers are actually saying about value. The stock shows mixed return figures, with a 7 day return of 8.3%, 30 day return of 2.0%, year to date return of 5.7%, a 1 year return of 108.0%, a 3 year return of 11.9% decline, and a 5 year return of 64.5% decline that some investors may see as a reset in expectations. Recent attention around Oncolytics...

BridgeBio Pharma (NasdaqGS:BBIO) reported long term data for acoramidis (Attruby) in transthyretin amyloid cardiomyopathy, showing sustained efficacy, safety and quality of life outcomes over several years. The company highlighted the role of early and continuous treatment for ATTR-CM patients, citing ongoing unmet medical needs with existing options. BridgeBio submitted a New Drug Application to the US FDA for BBP-418, supported by Phase 3 data in limb-girdle muscular dystrophy type...

Merit Medical Systems (NasdaqGS:MMSI) has acquired View Point Medical, expanding its presence in interventional medical devices. The company has also broadened its distribution agreement with Medtronic, widening access to Merit's products through Medtronic's channels. For investors watching NasdaqGS:MMSI, these moves come as the stock trades around $68.65, with a mixed return profile over recent periods. Shares show an 11.9% return over 5 years, alongside weaker performance over the past 1,...

On 9 April 2026, CoreWeave announced an expanded long-term agreement to supply Meta with AI cloud capacity through December 2032, worth about US$21.00 billion and including early deployments of NVIDIA’s Vera Rubin platform across multiple locations. This multi-year commitment deepens CoreWeave’s role as critical infrastructure for Meta’s AI ambitions while further diversifying its large-scale cloud customer base. We’ll now examine how this expanded Meta agreement, and its long-term revenue...

FedRAMP milestone puts Clear Secure in focus Clear Secure (YOU) is drawing fresh investor attention after its CLEAR1 platform received a FedRAMP "In Process" designation at the Moderate level, a key milestone for working with federal agencies. See our latest analysis for Clear Secure. While the FedRAMP news has put Clear Secure back on the radar, the share price tells its own story, with a 30 day share price return of 6.78% and a 90 day share price return of 34.37%, feeding into a 1 year...

Lowe's Companies (LOW) has been in focus after recent retail sales data and analyst upgrades coincided with a move higher in the share price, drawing fresh attention to the home improvement retailer. See our latest analysis for Lowe's Companies. The recent 7-day share price return of 7.26% and 1-day move of 1.70% suggest momentum has picked up again. This comes even though the 90-day share price return of 7.26% and 30-day share price return of 1.31% declines point to a softer patch over the...

In early April 2026, Reliance, Inc. urged shareholders via a definitive proxy filing to vote against an investor proposal that would require any director failing to secure a future majority vote in an uncontested election to leave the board within nine months, ahead of its May 20, 2026 annual meeting. At the same time, Reliance has been contending with geopolitical disruptions around the Israel-US-Iran conflict that are affecting operations through higher freight and insurance costs and...

In recent weeks, Trump Media & Technology Group has reportedly considered spinning off its Truth Social business while shifting toward fintech, cryptocurrencies, digital assets, and a nuclear fusion venture via a proposed merger with TAE Technologies and Texas Ventures III. This potential reconfiguration would move the company beyond its original social media roots, raising questions about how investors assess a business model spanning online communication, financial technology, and advanced...

Earlier this month, Comcast’s Xfinity expanded its StreamSaver bundles to include Disney+, Hulu, HBO Max, Netflix, Apple TV, and Peacock, while also enhancing its StreamStore platform to simplify how customers mix, match, and manage multiple streaming subscriptions on a single bill. By positioning itself as a central hub for premium streaming services, Comcast is leaning further into aggregation, aiming to deepen customer engagement across its broadband and entertainment ecosystem. We’ll now...

Omnicell (OMCL) has been on investors’ radar after recent trading left the shares with a one-month return of about a 9% decline and a past three-month move of roughly a 30% decline. See our latest analysis for Omnicell. At a share price of US$35.47, Omnicell’s 7 day share price return of 3.9% contrasts with a 30 day share price return of about a 9% decline and a year to date share price return of about a 21% decline. The 1 year total shareholder return of 14.1% shows the effect of holding...

Recent performance snapshot for Strategic Education Strategic Education (STRA) has drawn investor attention after recent share price moves, with the stock closing at US$82.46 and showing mixed returns over the past month and past 3 months. See our latest analysis for Strategic Education. For context, the recent 3.7% 1 month share price return comes after a modest 4.9% year to date share price gain and a 1 year total shareholder return of 8.0%. The 3 year total shareholder return remains...

Spire (NYSE:SR) has secured an $800 million senior unsecured term loan. The financing is intended to fund the acquisition of Piedmont Natural Gas Company's Nashville operations. The transaction represents a significant expansion of Spire's footprint in the Nashville, Tennessee area. Spire, trading at $95.19 per share, is moving ahead with one of its larger corporate moves in recent years by financing a sizeable acquisition in Nashville. The stock has returned 14.4% year to date and 32.7%...